Scleroderma laboratory findings: Difference between revisions
No edit summary |
|||
Line 24: | Line 24: | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
*Laboratory findings consistent with the diagnosis of scleroderma include:<ref name="pmid6155920">{{cite journal |vauthors=Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C |title=Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome |journal=Arthritis Rheum. |volume=23 |issue=6 |pages=617–25 |date=June 1980 |pmid=6155920 |doi= |url=}}</ref> | |||
**Antibody to Scl-70 antigen | |||
**Antibody to centromere (CREST syndrome) | |||
**Antinuclear antibody | |||
*Laboratory findings consistent with the diagnosis of | |||
** | |||
** | |||
** | |||
==References== | ==References== |
Revision as of 15:35, 18 April 2018
Scleroderma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Scleroderma laboratory findings On the Web |
American Roentgen Ray Society Images of Scleroderma laboratory findings |
Risk calculators and risk factors for Scleroderma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
OR
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
OR
[Test] is usually normal for patients with [disease name].
OR
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
OR
There are no diagnostic laboratory findings associated with [disease name].
Laboratory Findings
- Laboratory findings consistent with the diagnosis of scleroderma include:[1]
- Antibody to Scl-70 antigen
- Antibody to centromere (CREST syndrome)
- Antinuclear antibody